ICanSTEP : Increasing Physical Activity With Text Messaging

Completed · Not applicable

Conditions studied: A Diagnosis of Any Hematologic or Solid Malignancy

In brief

The proposed pilot study will develop and test feasibility and preliminary efficacy of an exercise motivation intervention using a 12-week smartphone-text messaging program tailored to physical activity data retrieved from a Fitbit. Target population is 15 cancer survivors and 15 patients actively undergoing cancer treatment.

Key facts

Study ID

NCT02627079

Run by

Duke University

People needed

30

Starts

2016-08-04

Expected to finish

2018-05-21

Last updated by the study team

2021-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible participants must be / have
• age 18 or older,
• a diagnosis of any hematologic or solid malignancy
• a life expectancy of at least 12 months
• ECOG < /=2
• in active cancer treatment or have completed active cancer treatment within one year of obtaining consent (with the exception of adjuvant hormonal therapy),
• not scheduled for any major surgery during the anticipated study period,
• able to read and understand English
• sedentary defined as participating in 2 or less days of dedicated physical activity per week,
• consistent daily access to a smartphone
• a text messaging plan that includes a minimum of 150 text messages a month at no additional cost
• capable of providing informed consent.

You may not qualify if…

• Significant cardiac disease (i.e., left ventricular ejection fraction of <50%, unstable angina, placement of cardiac stents and myocardial infarction within previous 6 months)
• Contraindications to a 6-minute walk test as recommended by the American Thoracic Society: (a) acute myocardial infarction (3-5 days), (b) unstable angina, (c) uncontrolled arrhythmias causing symptoms or hemodynamic compromise, (d) syncope, (e) acute endocarditis, (f) acute myocarditis or pericarditis, (g) uncontrolled heart failure, (h) acute pulmonary embolus or pulmonary infarction, (i) thrombosis of lower extremities, (j) suspected dissecting aneurysm, (k) uncontrolled asthma, (l) pulmonary edema, (m) room air desaturation at rest ≤85%, (n) respiratory failure, (o) acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise, (p) mental impairment leading to inability to cooperate, and (q) extensive bone metastases
• ECOG >2
• Participates in 3 or more days of dedicated physical activity per week
• Known allergic reaction to nickel
• No access to a smart phone or text messaging plan less than 150 messages per month
• Physical or psychological contraindication to participation at the discretion of the treating physician.

Where it is running

• Duke Cancer Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.